In this episode of I am BIO, we have two powerful stories. Each one is as different as the disease that it’s about. Yet there is a common thread: patients want and need to be heard. You will hear from a mom who will do whatever it takes to save her son’s life.  And you will learn about a young…

By Danielle Davis, MSW  Inclusion is one of Gilead’s core values, and it not only guides how our employees work together, but also supports our commitment to eliminating health and healthcare disparities. Integrating diversity into our research programs helps to ensure we have representation in…

The pandemic has heightened the need to advance health equity and, at Amgen, we continue to build upon our work to advance policies and practices in support of achieving health equity so that all people have an opportunity to be as healthy as possible. One of our strategic pillars…

This Hispanic Heritage Month, Good Day BIO will be highlighting the achievements of Hispanic and Latinx individuals who have eliminated barriers in the sciences, medicine, and biotechnology—here’s a list of 25 trailblazers you should know.

When BIO launched the BIO Equality Agenda last year, its goal was to counteract the systemic inequality, injustice and unfair treatment of underserved communities. Through its three pillars for change – Promote Health Equity, Invest in the Current and Next Generation of Scientists, and Expand…

Young women should be encouraged to pursue careers in science By Sulagna Bhattacharya CEO, Nanoscope Therapeutics, Bedford Texas With our nation emerging from the devastating COVID-19 pandemic, this is a good time to encourage more women to pursue science, technology, engineering and mathematics…

“You will have a better, stronger company which makes better decisions if you have diversity.” That’s how Dr. Ted Love, President and CEO of Global Blood Therapeutics (GBT), summed up the importance of diversity, equity, and inclusion (DEI) to the success of biotechnology companies during a…

June 2021 was a particularly special Pride Month for BIO—and not only because many of us got the chance to celebrate with our friends in person thanks to the COVID-19 vaccines. BIO was thrilled to announce our new chair, Paul Hastings, CEO of Nkarta Therapeutics—and the first openly LGBTQ chair of…

Black Americans have lost 3.25 years of life expectancy and Hispanic Americans have lost 3.88 years as a result of the COVID-19 pandemic, according to new research published by the British Medical Journal. This is just the latest among the longstanding health inequities brought to light by the…

BIO launched its BIOEquality Agenda to counteract systemic inequality, injustice and unfair treatment of underserved communities. Through this agenda, BIO focuses on three pillars for change: Promote Health Equity Invest in the Current and Next Generation of Scientists Expand Opportunity for…